Risk of Myocardial Infarction and Stroke with Single or Repeated Doses of Intravitreal Bevacizumab in Age-Related Macular Degeneration

American Journal of Ophthalmology

Volumn 163, Issue , 2016, Pages 53-58

  Etminan, Mahyar ^a,b   Maberley, David A ^b   Babiuk, David W ^c   Carleton, Bruce C ^a,b  

^a BC CHILDREN S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c PROVINCIAL HEALTH SERVICES AUTHORITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; BEVACIZUMAB; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

AGED; ANTAGONISTS AND INHIBITORS; BRITISH COLUMBIA; CASE CONTROL STUDY; CHEMICALLY INDUCED; COHORT ANALYSIS; FEMALE; FOLLOW UP; HUMAN; INTRAVITREAL DRUG ADMINISTRATION; MALE; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; STROKE; VERY ELDERLY; WET MACULAR DEGENERATION;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; BEVACIZUMAB; BRITISH COLUMBIA; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRAVITREAL INJECTIONS; MALE; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WET MACULAR DEGENERATION;

EID: 84959361928     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2015.11.030     Document Type: Article

References (23)

1. N. Ferrara, L. Damico, N. Shams, H. Lowman, and R. Kim Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration Retina 26 8 2006 859 870
2. L. Moja, E. Lucenteforte, K.H. Kwag, and et al. Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration Cochrane Database Syst Rev 9 2014 CD011230
3. A.A. Mosfeghi, P.J. Rosenfeld, C.A. Puliafito, and et al. Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration Ophthalmology 113 11 2006 2002 2011
4. CATT Research Group, D.F. Martin, M.G. Maguire, G.S. Ying, and et al. Ranibizumab and bevacizumab for neovascular age-related macular degeneration N Engl J Med 364 20 2011 1897 1908
5. L.H. Curtis, B.G. Hammill, K.A. Schulman, and S.W. Cousins Risks of mortality, myocardial infarction, bleeding, and stroke associated with therapies for age-related macular degeneration Arch Ophthalmol 128 10 2010 1273 1279
6. R.J. Campbell, S.S. Gill, S.E. Bronskill, J.M. Paterson, M. Whitehead, and C.M. Bell Adverse events with intravitreal injection of vascular endothelial growth factor inhibitors: nested case-control study BMJ 345 2012 e4203
7. M.B. Schlenker, D. Thiruchelvam, and D.A. Redelmeier Intravitreal anti-vascular endothelial growth factor treatment and the risk of thromboembolism Am J Ophthalmol 160 3 2015 569 580
8. F. Semeraro, F. Morescalchi, S. Duse, E. Gambicorti, M.R. Romano, and C. Costagliola Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: an overview Expert Opin Drug Saf 13 6 2014 785 802
9. S. Michels Is intravitreal bevacizumab (Avastin) safe? Br J Ophthalmol 90 11 2006 1333 1334
10. R.L. Avery, A.A. Castellarin, N.C. Steinle, and et al. Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD Br J Ophthalmol 98 12 2014 1636 1641
11. C. Zehetner, R. Kirchmair, S. Huber, M.T. Kralinger, and G.F. Kieselbach Plasma levels of vascular endothelial growth factor before and after intravitreal injection of bevacizumab, ranibizumab and pegaptanib in patients with age-related macular degeneration, and in patients with diabetic macular oedema Br J Ophthalmol 97 4 2013 454 459
12. IVAN Study Investigators, U. Chakravarthy, S.P. Harding, C.A. Rogers, and et al. Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial Ophthalmology 119 17 2012 1399 1411
13. [creator] (2012): Discharge Abstract Database (Hospital Separations). British Columbia Ministry of Health [publisher]. Data Extract. MOH (2012)Available at. Accessed November 2
14. British Columbia Ministry of Health [creator] (2012): Medical Services Plan (MSP) Payment Information File. British Columbia Ministry of Health [publisher]. Data Extract. MOH (2012). Available at http://www.health.gov.bc.ca/data/. Accessed November 2, 2015.
15. BC Ministry of Health [creator] (2012): PharmaNet. BC Ministry of Health [publisher]. Data Extract. MOH (2012). Avilable at http://www.health.gov.bc.ca/data/. Accessed November 2, 2015.
16. C. Varas-Lorenzo, J. Castellsague, M.R. Stang, and et al. Positive predictive value of ICD-9 codes 410 and 411 in the identification of cases of acute coronary syndromes in the Saskatchewan Hospital automated database Pharmacoepidemiol Drug Saf 17 8 2008 842 852
17. R.A. Kokotailo, and M.D. Hill Coding of stroke and stroke risk factors using international classification of diseases, revisions 9 and 10 Stroke J Cereb Circ 36 8 2005 1776 1781
18. M. Etminan, F. Forooghian, J.M. Brophy, S.T. Bird, and D. Maberley Oral fluoroquinolones and the risk of retinal detachment JAMA 307 13 2012 1414 1419
19. T. Zhang, M.A. Smith, P.G. Camp, S. Shajari, S.M. MacLeod, and B.C. Carleton Prescription drug dispensing profiles for one million children: a population-based analysis Eur J Clin Pharmacol 69 3 2013 581 588
20. J.H. Lubin Extensions of analytic methods for nested and population-based incident case-control studies J Chron Dis 39 5 1986 379 388
21. N.E. Breslow Statistics in epidemiology: the case-control study J Am Stat Assoc 91 433 1996 14 28
22. P.R. Rosenbaum, and D.B. Rubin The central role of the propensity score in observational studies for causal effects Biometrika 70 1 1983 41 55
23. M. Thulliez, D. Angoulvant, M.L. Le Lez, and et al. Cardiovascular events and bleeding risk associated with intravitreal antivascular endothelial growth factor monoclonal antibodies: systematic review and meta-analysis JAMA Ophthalmol 132 11 2014 1317 1326